While Mylan agreed to pay $465 million to resolve accusations it improperly classified EpiPens as a generic drug, the Canonsburg, Pa.-based drugmaker has yet to finalize the settlement with the ...

Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...

The publication spoke with 10 former Mylan executives who said they were not surprised the price is still so high. The unnamed executives said the drugmaker “has thrived by learning to absorb, and ...

(Reuters) - U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy ...

WASHINGTON (AP) — The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens and is signaling the company has no plans to lower prices despite a public outcry. “Price and ...

Mylan will make its generic to EpiPen available for purchase next week, according to npr. 1. The generic will cost half as much as EpiPen, carrying a list price of $300 for a two-pack. 2. In a ...

The Food and Drug Administration on Thursday approved the first generic version of EpiPen, providing new competition that could help drive down the cost of a lifesaving product that had become a ...

The maker of EpiPens will begin selling a cheaper, generic version of the emergency allergy shots as the furor over repeated U.S. price hikes continues -- and looming competition threatens its ...

(Reuters) - Mylan NV, which has come under fire for its drug pricing, said on Friday it would start selling a generic version of its life-saving EpiPen allergy treatment for $300 per two-pack, a more ...

Responding to national outrage over high prices, Mylan announced plans on Monday to launch a generic EpiPen at a 50% discount to the branded version of the life saving allergy treatment. Mylan (MYL) ...

NEW YORK (AP) – Mylan says it will make available a generic version of its EpiPen, as criticism continued to mount over the price of its injectable medicine. The company said Monday that its U.S.